1104455-41-5Relevant articles and documents
COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE
-
Paragraph 0932; 0933; 0934, (2018/05/27)
Provided herein, inter alia, are methods and compounds for modulating Interleukin-2-inducible T-cell kinase.
NITROGEN-CONTAINING HETEROCYCLIC COMPOUND
-
Paragraph 0267, (2017/08/01)
The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity and useful as a medicament such as a prophylactic or therapeutic drug for Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies and the like, and the like. The present invention relates to a compound represented by the formula (I) or a salt thereof. wherein each symbol is as described in the attached DESCRIPTION.
2,4-DIAMINO-PYRIMIDINE DERIVATIVES
-
Page/Page column 62-63, (2009/03/07)
The invention concerns compounds of Formula (I), or a pharmaceutically acceptable salt thereof, where R1, Q, R3, and R4 are as defined in the description. The present invention also relates to processes for the preparation ofsuch compounds, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an antiproliferative agent in the prevention or treatment of tumours or other proliferative conditions which are sensitive to the inhibition of EphB4 kinases.